Skip to main content
SpringerLink
Log in
Book cover

Pediatric Nephrology pp 1–21Cite as

Renal Involvement in Children with Vasculitis

  • 335 Accesses

Abstract

Vasculitis is the inflammation in a blood vessel wall. This inflammation leads to narrowing or aneurysm of the vessel resulting in protean manifestations in the tissue that it nourishes. The kidney is one of the target organs frequently affected in vasculitis.

This is a preview of subscription content, log in via an institution.

References

  1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  CAS  PubMed  Google Scholar 

  2. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–34.

    Article  CAS  PubMed  Google Scholar 

  3. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33(8):1101–7.

    Article  CAS  PubMed  Google Scholar 

  4. Lightfoot Jr RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33(8):1088–93.

    Article  PubMed  Google Scholar 

  5. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65:936–41.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798–806.

    Article  PubMed  Google Scholar 

  7. Kawasaki T. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi. 1967;16(3):178–222.

    CAS  PubMed  Google Scholar 

  8. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114(6):1708–33.

    Article  PubMed  Google Scholar 

  9. Sundel RP, Petty RE. Kawasaki disease. In: Cassidy J, Petty R, Laxer R, Lindsley C, editors. Textbook of pediatric rheumatology. 5th ed. Philadelphia: Elsevier; 2005. p. 521–38.

    Chapter  Google Scholar 

  10. Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child. 2002;86(4):286–90.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Nardi PM, Haller JO, Friedman AP, Slovis TL, Schaffer RM. Renal manifestations of Kawasaki’s disease. Pediatr Radiol. 1985;15(2):116–18.

    Article  CAS  PubMed  Google Scholar 

  12. Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Sterile pyuria in patients with Kawasaki disease originates from both the urethra and the kidney. Pediatr Nephrol. 2007;22(7):987–91.

    Article  PubMed  Google Scholar 

  13. Bonany PJ, Bilkis MD, Gallo G, Lago N, Dennehy MV, Sosa del Valle JM, et al. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol. 2002;17(5):329–31.

    Article  PubMed  Google Scholar 

  14. Mac Ardle BM, Chambers TL, Weller SD, Tribe CR. Acute renal failure in Kawasaki disease. J R Soc Med. 1983;76(7):615–16.

    CAS  PubMed Central  PubMed  Google Scholar 

  15. Sevin C, Heidet L, Gagnadoux MF, Cheron G, Niaudet P. [Acute renal insufficiency in Kawasaki disease]. Arch Fr Pediatr. 1993;50(6):505–7.

    CAS  PubMed  Google Scholar 

  16. Veiga PA, Pieroni D, Baier W, Feld LG. Association of Kawasaki disease and interstitial nephritis. Pediatr Nephrol. 1992;6(5):421–3.

    Article  CAS  PubMed  Google Scholar 

  17. Krug P, Boyer O, Balzamo E, Sidi D, Lehnert A, Niaudet P. Nephrotic syndrome in Kawasaki disease: a report of three cases. Pediatr Nephrol. 2012;27(9):1547–50.

    Article  PubMed  Google Scholar 

  18. Amano S, Hazama F, Hamashima Y. Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions. Jpn Circ J. 1979;43(8):741–8.

    Article  CAS  PubMed  Google Scholar 

  19. Takahashi K, Oharaseki T, Yokouchi Y, Naoe S, Saji T. Kawasaki disease: basic and pathological findings. Clin Exp Nephrol. 2013;17(5):690–3.

    Article  PubMed  Google Scholar 

  20. Valentini RP, Smoyer WE. Renal vasculitis. In: Avner E, Harmon W, Niaudet P, editors. Pediatric nephrology. 5th ed. Philadelphia: Lippincott Williams Wilkins; 2004. p. 835–50.

    Google Scholar 

  21. Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum. 2003;49(5):709–15.

    Article  PubMed  Google Scholar 

  22. Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145(4):517–22.

    Article  PubMed  Google Scholar 

  23. Thibault S, Drolet R, Germain MC, D’Allaire S, Larochelle R, Magar R. Cutaneous and systemic necrotizing vasculitis in swine. Vet Pathol. 1998;35(2):108–16.

    Article  CAS  PubMed  Google Scholar 

  24. Ozen S, Ben-Chetrit E, Bakkaloglu A, Gur H, Tinaztepe K, Calguneri M, et al. Polyarteritis nodosa in patients with Familial Mediterranean Fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum. 2001;30(4):281–7.

    Article  CAS  PubMed  Google Scholar 

  25. Bakkaloglu A, Ozen S, Baskin E, Besbas N, Gur-Guven A, Kasapcopur O, et al. The significance of antineutrophil cytoplasmic antibody in microscopic polyangiitis and classic polyarteritis nodosa. Arch Dis Child. 2001;85(5):427–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Brogan PA, Davies R, Gordon I, Dillon MJ. Renal angiography in children with polyarteritis nodosa. Pediatr Nephrol. 2002;17(4):277–83.

    Article  PubMed  Google Scholar 

  27. Jelusic M, Vikic-Topic M, Batinic D, Milosevic D, Malenica B, Malcic I. Polyarteritis nodosa in Croatian children: a retrospective study over the last 20 years. Rheumatol Int. 2013;33(12):3087–90.

    Article  PubMed  Google Scholar 

  28. Mondal R, Sarkar S, Pal P, Nandi M, Hazra A, Sabui TK. Childhood polyarteritis nodosa: a prospective multicentre study from eastern India. Indian J Pediatr. 2014;81(4):371–4.

    Article  PubMed  Google Scholar 

  29. Hall LD, Dalton SR, Fillman EP, Dohse L, Elston DM. Re-examination of features to distinguish polyarteritis nodosa from superficial thrombophlebitis. Am J Dermatopathol. 2013;35(4):463–71.

    Article  PubMed  Google Scholar 

  30. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus. 1998;7(4):238–58.

    Article  CAS  PubMed  Google Scholar 

  31. Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911–20.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine. 2005;84(5):323–30.

    Article  PubMed  Google Scholar 

  33. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44(3):666–75.

    Article  CAS  PubMed  Google Scholar 

  34. Leib ES, Restivo C, Paulus HE. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med. 1979;67(6):941–7.

    Article  CAS  PubMed  Google Scholar 

  35. Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol. 2006;2(12):661–70.

    Article  CAS  PubMed  Google Scholar 

  36. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110(7):955–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum. 1999;42(3):421–30.

    Article  CAS  PubMed  Google Scholar 

  39. Hattori M, Kurayama H, Koitabashi Y, Japanese Society for Pediatric N. Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol. 2001;12(7):1493–500.

    CAS  PubMed  Google Scholar 

  40. Peco-Antic A, Bonaci-Nikolic B, Basta-Jovanovic G, Kostic M, Markovic-Lipkovski J, Nikolic M, et al. Childhood microscopic polyangiitis associated with MPO-ANCA. Pediatr Nephrol. 2006;21(1):46–53.

    Article  PubMed  Google Scholar 

  41. Handa R, Wali JP, Gupta SD, Dinda AK, Aggarwal P, Wig N, et al. Classical polyarteritis nodosa and microscopic polyangiitis – a clinicopathologic study. J Assoc Physicians India. 2001;49:314–19.

    CAS  PubMed  Google Scholar 

  42. Yu F, Huang JP, Zou WZ, Zhao MH. The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children. Pediatr Nephrol. 2006;21(4):497–502.

    Article  PubMed  Google Scholar 

  43. Ben Ameur S, Niaudet P, Baudouin V, Le Bourgeois M, Houdouin V, Delacourt C, et al. Lung manifestations in MPO-ANCA associated vasculitides in children. Pediatr Pulmonol. 2014;49(3):285–90.

    Article  PubMed  Google Scholar 

  44. Jennette JC, Thomas DB, Falk RJ. Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol. 2001;18(1):3–13.

    CAS  PubMed  Google Scholar 

  45. Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363(3):211–20.

    Article  CAS  PubMed  Google Scholar 

  46. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52(8):2461–9.

    Article  PubMed  Google Scholar 

  48. Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, et al. A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis. 1992;20(3):261–9.

    Article  CAS  PubMed  Google Scholar 

  49. Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Genereau T, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum. 1995;38(11):1638–45.

    Article  CAS  PubMed  Google Scholar 

  50. Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180–8.

    Article  CAS  PubMed  Google Scholar 

  51. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int. 1991;40(4):757–63.

    Article  CAS  PubMed  Google Scholar 

  52. Zauner I, Bach D, Braun N, Kramer BK, Funfstuck R, Helmchen U, et al. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis. Am J Kidney Dis. 2002;39(1):28–35.

    Article  PubMed  Google Scholar 

  53. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36–44.

    Article  CAS  PubMed  Google Scholar 

  54. Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359(26):2790–803.

    Article  CAS  PubMed  Google Scholar 

  55. Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA. 2010;304(21):2381–8.

    Article  CAS  PubMed  Google Scholar 

  56. Pendergraft 3rd WF, Cortazar FB, Wenger J, Murphy AP, Rhee EP, Laliberte KA, et al. Long-term maintenance therapy using rituximab-induced continuous B-cell depletion in patients with ANCA vasculitis. Clin J Am Soc Nephrol. 2014;9(4):736–44.

    Article  CAS  PubMed  Google Scholar 

  57. Harper L, Savage CO. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol. 2000;190(3):349–59.

    Article  CAS  PubMed  Google Scholar 

  58. De Lind van Wijngaarden RA, van Rijn L, Hagen EC, Watts RA, Gregorini G, Tervaert JW, et al. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol. 2008;3(1):237–52.

    Article  PubMed  Google Scholar 

  59. Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, et al. Clinical features and outcome of pediatric Wegener’s granulomatosis. Arthritis Rheum. 2007;57(5):837–44.

    Article  CAS  PubMed  Google Scholar 

  60. Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002;17(9):754–61.

    Article  PubMed  Google Scholar 

  61. Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr. 2004;163(8):425–34.

    Article  PubMed  Google Scholar 

  62. Siomou E, Tramma D, Bowen C, Milford DV. ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome. Pediatr Nephrol. 2012;27(10):1911–20.

    Article  PubMed  Google Scholar 

  63. Stegmayr BG, Gothefors L, Malmer B, Muller Wiefel DE, Nilsson K, Sundelin B. Wegener granulomatosis in children and young adults. A case study of ten patients. Pediatr Nephrol. 2000;14(3):208–13.

    Article  CAS  PubMed  Google Scholar 

  64. Khan I, Watts RA. Classification of ANCA-associated vasculitis. Curr Rheumatol Rep. 2013;15(12):383.

    Article  PubMed  Google Scholar 

  65. Harper L, Morgan MD, Walsh M, Hoglund P, Westman K, Flossmann O, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2012;71(6):955–60.

    Article  CAS  PubMed  Google Scholar 

  66. Wegener’s Granulomatosis Etanercept Trial Research G. Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med. 2005;352(4):351–61.

    Article  Google Scholar 

  67. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med. 1996;335(1):16–20.

    Article  CAS  PubMed  Google Scholar 

  68. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–100.

    Article  CAS  PubMed  Google Scholar 

  69. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine. 1999;78(1):26–37.

    Article  CAS  PubMed  Google Scholar 

  70. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005;17(1):16–24.

    Article  CAS  PubMed  Google Scholar 

  71. de Pablo P, Garcia-Torres R, Uribe N, Ramon G, Nava A, Silveira LH, et al. Kidney involvement in Takayasu arteritis. Clin Exp Rheumatol. 2007;25(1 Suppl 44):S10–14.

    PubMed  Google Scholar 

  72. Vaideeswar P, Deshpande JR. Pathology of Takayasu arteritis: a brief review. Ann Pediatr Cardiol. 2013;6(1):52–8.

    Article  PubMed Central  PubMed  Google Scholar 

  73. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68(3):318–23.

    Article  CAS  PubMed  Google Scholar 

  74. Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. 2007;150(1):72–6.

    Article  CAS  PubMed  Google Scholar 

  75. Abisror N, Mekinian A, Lavigne C, Vandenhende MA, Soussan M, Fain O, et al. Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review. Autoimmun Rev. 2013;12(12):1143–9.

    Article  CAS  PubMed  Google Scholar 

  76. Evaluation of diagnostic (‘classification’) criteria in Behcet’s disease – towards internationally agreed criteria. The International Study Group for Behcet’s disease. Br J Rheumatol. 1992;31(5):299–308.

    Google Scholar 

  77. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S. Renal Behcet’s disease: a cumulative analysis. Semin Arthritis Rheum. 2002;31(5):317–37.

    Article  PubMed  Google Scholar 

  78. Dolezalova P, Price-Kuehne FE, Ozen S, Benseler SM, Cabral DA, Anton J, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). Ann Rheum Dis. 2013;72(10):1628–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Faculty of Medicine, Hacettepe University, 06100, Sihhiye, Ankara, Turkey

    Seza Ozen

  2. Department of Pediatric Pathology, Hacettepe University, 06100, Sihhiye, Ankara, Turkey

    Diclehan Orhan

Authors
  1. Seza Ozen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diclehan Orhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seza Ozen .

Editor information

Editors and Affiliations

  1. Children's Hospital of Wisconsin Children's Research Institute, Milwaukee, Wisconsin, USA

    Ellis D. Avner

  2. Harvard Medical School Children's Hospital Boston, Boston, Massachusetts, USA

    William E. Harmon

  3. Hôpital Necker Enfants Malades Dept. Néphrologie Pédiatrique, Paris, France

    Patrick Niaudet

  4. Wakayama Medical University Dept. Pediatrics, Wakayama City, Japan

    Norishige Yoshikawa

  5. Department of Nephrology and Urology Division of Nephrology, Children's Hospital Bambino Gesù, IRCCS, Rome, Italy

    Francesco Emma

  6. Division of Nephrology and Hypertension The Heart Institute, University of Cincinnati Cincinnati Children’s Hospital Medical C, Cincinnati, Ohio, USA

    Stuart Goldstein

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Ozen, S., Orhan, D. (2014). Renal Involvement in Children with Vasculitis. In: Avner, E., Harmon, W., Niaudet, P., Yoshikawa, N., Emma, F., Goldstein, S. (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27843-3_41-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27843-3_41-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27843-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Renal Vasculitis
    Published:
    25 September 2021

    DOI: https://doi.org/10.1007/978-3-642-27843-3_41-2

  2. Original

    Renal Involvement in Children with Vasculitis
    Published:
    17 November 2014

    DOI: https://doi.org/10.1007/978-3-642-27843-3_41-1

Search

Navigation